Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genomics02:02

Genomics

36.3K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
36.3K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multiplex networks-based directed graph neural network for cancer driver gene identification.

PLoS computational biology·2026
Same author

DriverMEDS: Cancer driver gene identification using mutual exclusivity from embeded features and driver mutation scoring.

Methods (San Diego, Calif.)·2025
Same author

Restless Legs Syndrome in Hemodialysis Patients: Clinical and Electrophysiological Study.

Journal of multidisciplinary healthcare·2024
Same author

Multi-view contrastive clustering for cancer subtyping using fully and weakly paired multi-omics data.

Methods (San Diego, Calif.)·2024
Same author

DrugDoctor: enhancing drug recommendation in cold-start scenario via visit-level representation learning and training.

Briefings in bioinformatics·2024
Same author

Polypharmacy side effect prediction based on semi-implicit graph variational auto-encoder.

Journal of bioinformatics and computational biology·2024

Related Experiment Video

Updated: Jun 24, 2025

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

1.5K

Subtype-MGTP: a cancer subtype identification framework based on multi-omics translation.

Minzhu Xie1,2,3, Yabin Kuang1, Mengyun Song1

  • 1College of Information Science and Engineering, Hunan Normal University, Changsha 410081, China.

Bioinformatics (Oxford, England)
|June 10, 2024
PubMed
Summary
This summary is machine-generated.

This study introduces Subtype-MGTP, a novel framework for cancer subtyping that integrates genomics and protein data. Subtype-MGTP accurately identifies cancer subtypes by translating genomics into protein data and employing deep subspace clustering, outperforming existing methods.

More Related Videos

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

2.6K
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.4K

Related Experiment Videos

Last Updated: Jun 24, 2025

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

1.5K
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

2.6K
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.4K

Area of Science:

  • Computational biology
  • Bioinformatics
  • Cancer research

Background:

  • Cancer subtyping is crucial for research and treatment, with multi-omics data integration offering an efficient strategy.
  • Current methods often rely on genomics data, but protein expression data provides a closer phenotypic representation.
  • Integrating scarce protein data with genomics data for cancer subtyping presents significant challenges, including data scarcity and balancing omics-specific and cross-omics learning.

Purpose of the Study:

  • To develop a novel cancer subtyping framework, Subtype-MGTP, that effectively integrates multi-omics data, particularly addressing the challenge of limited protein expression data.
  • To enhance cancer subtyping accuracy by leveraging predicted protein expression data derived from genomics data.
  • To improve the integration of omics-specific and cross-omics learning in multi-omics data analysis.

Main Methods:

  • Subtype-MGTP framework utilizes a translation module to predict protein expression from multi-type genomics data, guided by available protein data.
  • An improved deep subspace clustering module with contrastive learning is employed to cluster the predicted protein expression data for refined subtyping.
  • The framework is evaluated on benchmark datasets against nine state-of-the-art cancer subtyping methods.

Main Results:

  • Subtype-MGTP significantly outperforms nine existing state-of-the-art cancer subtyping methods on benchmark datasets.
  • The identified cancer subtypes demonstrate interpretability through clinical and survival analysis.
  • The framework shows robustness to missing protein data and excels in integrating imbalanced multi-omics datasets.

Conclusions:

  • Subtype-MGTP offers a powerful and robust approach for cancer subtyping by effectively integrating multi-omics data, particularly when protein data is limited.
  • The novel translation and deep subspace clustering modules enhance subtyping accuracy and provide interpretable results.
  • This framework advances multi-omics data integration strategies for cancer research and personalized medicine.